BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17609663)

  • 1. COX2 genetic variation, NSAIDs, and advanced prostate cancer risk.
    Cheng I; Liu X; Plummer SJ; Krumroy LM; Casey G; Witte JS
    Br J Cancer; 2007 Aug; 97(4):557-61. PubMed ID: 17609663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No association between cyclooxygenase-2 and uridine diphosphate glucuronosyltransferase 1A6 genetic polymorphisms and colon cancer risk.
    Thompson CL; Plummer SJ; Merkulova A; Cheng I; Tucker TC; Casey G; Li L
    World J Gastroenterol; 2009 May; 15(18):2240-4. PubMed ID: 19437564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variation in the COX-2 gene and the association with prostate cancer risk.
    Shahedi K; Lindström S; Zheng SL; Wiklund F; Adolfsson J; Sun J; Augustsson-Bälter K; Chang BL; Adami HO; Liu W; Grönberg H; Xu J
    Int J Cancer; 2006 Aug; 119(3):668-72. PubMed ID: 16506214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COX-2 promoter polymorphisms and the association with prostate cancer risk in South African men.
    Fernandez P; de Beer PM; van der Merwe L; Heyns CF
    Carcinogenesis; 2008 Dec; 29(12):2347-50. PubMed ID: 18974063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of association between the cyclooxygenase 2 -765G>C polymorphism and prostate cancer risk: a meta-analysis.
    Feng YQ; Li YU; Xiao WD; Wang GX; Li YO
    Genet Mol Res; 2015 Oct; 14(4):13391-402. PubMed ID: 26535654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Joint effect between regular use of non-steroidal anti-inflammatory drugs, variants in inflammatory genes and risk of lymphoma.
    Hoeft B; Becker N; Deeg E; Beckmann L; Nieters A
    Cancer Causes Control; 2008 Mar; 19(2):163-73. PubMed ID: 18038187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common genetic variation in IGF1 and prostate cancer risk in the Multiethnic Cohort.
    Cheng I; Stram DO; Penney KL; Pike M; Le Marchand L; Kolonel LN; Hirschhorn J; Altshuler D; Henderson BE; Freedman ML
    J Natl Cancer Inst; 2006 Jan; 98(2):123-34. PubMed ID: 16418515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase 2 genotypes influence prostate cancer susceptibility in Japanese Men.
    Sugie S; Tsukino H; Mukai S; Akioka T; Shibata N; Nagano M; Kamoto T
    Tumour Biol; 2014 Mar; 35(3):2717-21. PubMed ID: 24203817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A haplotype of cyclooxygenase-2 gene is associated with idiopathic pulmonary fibrosis.
    Xaubet A; Fu WJ; Li M; Serrano-Mollar A; Ancochea J; Molina-Molina M; Rodriguez-Becerra E; Morell F; Rodríguez-Arias JM; Pereda J; Casanova A; Molins L; Picado C
    Sarcoidosis Vasc Diffuse Lung Dis; 2010 Jul; 27(2):121-30. PubMed ID: 21319594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms in the cyclooxygenase-1 and cyclooxygenase-2 genes and risk of colorectal adenoma.
    Gong Z; Bostick RM; Xie D; Hurley TG; Deng Z; Dixon DA; Zhang J; Hebert JR
    Int J Colorectal Dis; 2009 Jun; 24(6):647-54. PubMed ID: 19205707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms in genes related to inflammation, NSAID use, and the risk of prostate cancer among Danish men.
    Kopp TI; Friis S; Christensen J; Tjønneland A; Vogel U
    Cancer Genet; 2013; 206(7-8):266-78. PubMed ID: 23880210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase 2 (rs2745557) Polymorphism and the Susceptibility to Benign Prostate Hyperplasia and Prostate Cancer in Egyptians.
    Fawzy MS; Elfayoumi AR; Mohamed RH; Fatah IRA; Saadawy SF
    Biochem Genet; 2016 Jun; 54(3):326-336. PubMed ID: 26920155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptor 4 genetic variation and advanced prostate cancer risk.
    Cheng I; Plummer SJ; Casey G; Witte JS
    Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):352-5. PubMed ID: 17301271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COX-1 (PTGS1) and COX-2 (PTGS2) polymorphisms, NSAID interactions, and risk of colon and rectal cancers in two independent populations.
    Makar KW; Poole EM; Resler AJ; Seufert B; Curtin K; Kleinstein SE; Duggan D; Kulmacz RJ; Hsu L; Whitton J; Carlson CS; Rimorin CF; Caan BJ; Baron JA; Potter JD; Slattery ML; Ulrich CM
    Cancer Causes Control; 2013 Dec; 24(12):2059-75. PubMed ID: 24022467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonsteroidal anti-inflammatory drugs (NSAIDs) and prostate cancer risk: results from the EPICAP study.
    Doat S; Cénée S; Trétarre B; Rebillard X; Lamy PJ; Bringer JP; Iborra F; Murez T; Sanchez M; Menegaux F
    Cancer Med; 2017 Oct; 6(10):2461-2470. PubMed ID: 28941222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3).
    Dossus L; Kaaks R; Canzian F; Albanes D; Berndt SI; Boeing H; Buring J; Chanock SJ; Clavel-Chapelon F; Feigelson HS; Gaziano JM; Giovannucci E; Gonzalez C; Haiman CA; Hallmans G; Hankinson SE; Hayes RB; Henderson BE; Hoover RN; Hunter DJ; Khaw KT; Kolonel LN; Kraft P; Ma J; Le Marchand L; Lund E; Peeters PH; Stampfer M; Stram DO; Thomas G; Thun MJ; Tjonneland A; Trichopoulos D; Tumino R; Riboli E; Virtamo J; Weinstein SJ; Yeager M; Ziegler RG; Cox DG
    Carcinogenesis; 2010 Mar; 31(3):455-61. PubMed ID: 19965896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between variants in the cyclooxygenase 2 enzyme gene (PTGS2) and development of benign prostate enlargement.
    St Sauver JL; Lieber MM; Slager SL; Jacobson DJ; McGree ME; Jacobsen SJ
    BJU Int; 2011 Nov; 108(10):1610-5. PubMed ID: 21481131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphisms in the cyclooxygenase-2 gene, use of nonsteroidal anti-inflammatory drugs, and breast cancer risk.
    Shen J; Gammon MD; Terry MB; Teitelbaum SL; Neugut AI; Santella RM
    Breast Cancer Res; 2006; 8(6):R71. PubMed ID: 17181859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A meta-analysis of PTGS1 and PTGS2 polymorphisms and NSAID intake on the risk of developing cancer.
    Nagao M; Sato Y; Yamauchi A
    PLoS One; 2013; 8(8):e71126. PubMed ID: 23967159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The COX2 genetic variants in oral squamous cell carcinoma in Turkish population.
    Cacina C; Kaşarci G; Bektaş K; Unur M; Cakmakoglu B
    Cell Mol Biol (Noisy-le-grand); 2018 Nov; 64(14):96-100. PubMed ID: 30511628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.